A5025508369- Lymphoma Diagnosis and Treatment
- Esophageal and GI Pathology
- Gastrointestinal disorders and treatments
- Liver physiology and pathology
- Pancreatitis Pathology and Treatment
- Quantum Chromodynamics and Particle Interactions
- Hematological disorders and diagnostics
- Particle physics theoretical and experimental studies
- High-Energy Particle Collisions Research
- Tracheal and airway disorders
- Lung Cancer Treatments and Mutations
- Diet and metabolism studies
- Pancreatic function and diabetes
- Dysphagia Assessment and Management
- Diet, Metabolism, and Disease
- Gut microbiota and health
- Gallbladder and Bile Duct Disorders
Affiliated Hospital of Chengde Medical College
2024
Second Hospital of Hebei Medical University
2022-2024
Hebei Medical University
2022-2024
Diabetic cognitive impairment(DCI) presents as a central nervous complication of diabetes especially among aging population. Melatonin (MEL) is known for its antioxidant and anti-inflammation effects in neuroprotective aspects. Recent evidence has demonstrated that the gut microbiome plays key role DCI by modulating function through gut-brain crosstalk. MEL been shown to modulate microbiota composition diabetic model. However, underlying mechanism which contributes remains unclear. This...
To analyze the factors affecting delayed chemotherapy in children with Burkitt lymphoma (BL) and their influence on prognosis.
A 36-year-old man underwent endoscopic retrograde cholangiopancreatography (ERCP) at a local hospital for chronic pancreatitis, after which the broken end of guidewire remained in pancreatic duct. The patient had intermittent postoperative abdominal discomfort and was referred to our hospital.
To analyze the mid-term efficacy of China Net Childhood Lymphoma mature B-cell lymphoma 2017 (CNCL-B-NHL-2017) regimen in treating children with high-grade (HGBL).
Objective: To analyze the clinical characteristics of children with Burkitt lymphoma (BL) and to summarize mid-term efficacy China Net Childhood Lymphoma-mature B-cell 2017 (CNCL-B-NHL-2017) regimen. Methods: Clinical features 436 BL patients who were ≤18 years old treated CNCL-B-NHL-2017 regimen from May April 2021 analyzed retrospectively. at disease onset therapeutic effects different stages risk groups compared. Survival analysis was performed by Kaplan-Meier method, Cox regression used...